Chugai Pharmaceutical Co., Ltd.

4519.T
Drug Manufacturers - General
2026/08/07 Updated
Market Cap: $71.2B (¥11.3T)
Stock Price: $43.28 (¥6,837)
Exchange Rate: 1 USD = ¥157.98

Q1 Financial Summary for the Fiscal Year Ending December 2026 [IFRS] (Consolidated)

In Q1 of the fiscal year ending December 2026, revenue reached JPY 321.7 billion (11.5% YoY increase), operating income was JPY 158.8 billion (16.2% YoY increase), and quarterly profit was JPY 115.4 billion (18.7% YoY increase). The number of outstanding shares was 1,679,057,667 shares.

Importance:
Page Updated: April 24, 2026
IR Disclosure Date: April 24, 2026

Key Figures

  • Revenue: JPY 321.7 billion (11.5% YoY increase)
  • Operating Income: JPY 158.8 billion (16.2% YoY increase)
  • Quarterly Profit: JPY 115.4 billion (18.7% YoY increase)

AI要約

Performance Overview

In Q1 of the fiscal year ending December 2026, consolidated revenue was JPY 321.7 billion (11.5% YoY increase), operating income was JPY 158.8 billion (16.2% YoY increase), and quarterly profit stood at JPY 115.4 billion (18.7% YoY increase). Product sales amounted to JPY 291.6 billion (12.3% YoY increase), supported by growth in key and new products both domestically and internationally. Research and development expenses were JPY 41.9 billion (2.9% YoY increase), and selling, general and administrative expenses were JPY 24.9 billion (18.6% YoY increase), affected by higher corporate enterprise taxes. Core operating income was JPY 163.3 billion (17.1% YoY increase), and Core quarterly profit was JPY 118.6 billion (19.6% YoY increase).

Financial Position and Cash Flow Status

At the end of Q1, total assets stood at JPY 2.2651 trillion, total net assets were JPY 1.9077 trillion, resulting in a net asset ratio of 84.2%. Net cash decreased by JPY 129.6 billion from the previous period to JPY 850.1 billion. Cash flow from operating activities was JPY 122.0 billion (82.9% YoY increase), and free cash flow was JPY 112.2 billion (162.8% YoY increase). The dividend forecast remains unchanged at JPY 132 annually, down from JPY 272 in the prior period which included the 100th anniversary commemorative dividend.

YoY Trends in Revenue

YoY Trends in Operating Income

YoY Trends in Quarterly Profit

Regional Composition of Product Sales in Q1 2026

Annual Dividend Trends

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Chugai Pharmaceutical Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →